HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nephrotoxicity of the flame retardant tris(2,3-dibromopropyl)phosphate.

Abstract
The flame retardant tris(2,3-dibromopropyl)phosphate (Tris-BP) is known to be activated to a potent mutagen in the Salmonella test system and to induce kidney tumors in long-term feeding studies in mice and rats. Administration of Tris-BP to rats leads to extensive tubular necrosis at doses of 250 mg/kg i.p. and higher. The histological lesion is present in most animals 24 h after administration. There is a close correlation between the increase in kidney weights, the degree of kidney damage and the increase in plasma urea levels. A continuous increase in kidney weights with respect to time is seen, 7 days after a dose of 250 mg/kg i.p. the kidney/body weight ratio is 192% of controls. The kidney damage is not altered by previous phenobarbital-treatment, whereas cobaltous chloride, an inhibitor of cytochrome P-450, slightly reduces the kidney damage.
AuthorsE Dybing, E Søderlund
JournalArchives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement (Arch Toxicol Suppl) Vol. 4 Pg. 219-22 ( 1980) ISSN: 0171-9750 [Print] Germany
PMID6933906 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Flame Retardants
  • Hydrocarbons, Brominated
  • Organophosphates
  • Organophosphorus Compounds
  • tris(2,3-dibromopropyl)phosphate
Topics
  • Animals
  • Flame Retardants (toxicity)
  • Hydrocarbons, Brominated (toxicity)
  • Kidney Diseases (chemically induced, pathology)
  • Male
  • Necrosis (pathology)
  • Organ Size (drug effects)
  • Organophosphates
  • Organophosphorus Compounds (toxicity)
  • Rats
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: